Introduction
Epigenetics encompasses the changes in gene expression triggered by environmental cues that occur without altering the underlying DNA sequences. Although epigenetics involves a limited number of identified mechanisms so far (DNA methylation, histone modifications and noncoding RNAs), the field of Epigenetics is spreading rapidly over integrated physiopathology (Jeffries, 2020). The importance of epigenetics has been acknowledged in cancer (Sun et al., 2022), sepsis (Binnie et al., 2020), autoimmune/inflammatory diseases (Surace and Hedrich, 2019), addiction (Hamilton and Nestler, 2019), aging (Pal and Tyler, 2016; Pérez et al., 2022), neurodegenerative diseases (Berson et al., 2018; Zhang et al., 2022) and even in neurodevelopmental (Esposito et al., 2018; Wu et al., 2020) and psychiatric diseases (Abdolmaleky et al., 2023). Likewise, a broad and expanding set of therapies in clinics have been potentialized by tuning the vagal complex of brainstem, i.e., the key neural node of homeostasis, via non-invasive Vagus Nerve Stimulation (VNS) (Hilz, 2022). Moreover, Heart Rate Variability (HRV), a physiologically validated and easily accessible read-out of the vagal tone (Lewis et al., 2012), is acknowledged as a polyvalent prognostic tool (Gidron et al., 2018; Mol et al., 2021). This is not surprising, since Epigenome is considered as a “mediator for host-microbiome crosstalk” (Peery et al., 2021) and since vagus nerve represents the fastest pathway of the Microbiota-Gut-brain Axis (Fülling et al., 2019). However, except for regulating neuro-inflammation (Chen et al., 2022), the mechanisms through which VNS influences peripheral and central nervous system plasticity are not well described yet, limiting therapeutic optimization (Morrison et al., 2020; Keute and Gharabaghi, 2021). Therefore, as the vagal complex (i.e., peripheral and brainstem components) is definitely prone to bring about epigenetic modulations, notably through neuro-endocrine stimuli (Gil et al., 2013), we questioned the epigenetic role of vagus nerve, in order to promote noninvasive VNS, guided by HRV monitoring, as a universal therapy to stay healthy.
Given the lack of evidence in the mentioned areas, this Research Topic aimed to.
1) update the key role of the brainstem vagal center in global homeostasis and health, and its position as bidirectional interface for neuro-immune interactions (bottom-up and top-down) in both animal models and clinical studies.
2) Assess the epigenetic mechanisms mediating adaptations of homeostatic reflexes and HRV inside the vagal complex of brainstem with focus on the differential effects of electrical parameters used.
3) Draw a research roadmap for assessing VNS as a putative efficient preventive therapy for improving health during an extended span.
A summary of the article contribution
This Research Topic gathered four articles, two original research study in Humans (Maharjan et al.; Konakoglu et al.), one original research study in a rat model (Carnevali et al.) and one review. HRV was specifically assessed in two studies (Maharjan et al.; Carnevali et al.).
The first study by Maharjan et al. documents the use of olfactory stimulation, instead of the more prevalent use of electrical stimulation, as a method of vagal nerve neuromodulation. Their paper illustrates the potent impact of olfactory stimulation in mediating autonomic changes. Their study is the first to establish a dose- and duration-specific effects of odors on the human Autonomic Nervous System (ANS). This study illustrates that there are other pathways of neuromodulation that may involve sensory stimuli that are not solely traveling through afferent pathways that directly influence the vagus that have frequently defined the domain of VNS. Their study has conceptual features similar to earlier studies applying other sensory stimuli such as music that has been interpreted as an “acoustic” vagal nerve stimulation (Porges et al., 2014; Rajabalee et al., 2022). Interestingly, this olfactive neuromodulation happens to impact specifically the vagal component of the ANS (but not the sympathetic one), suggesting that the vagal response profiles may be more modifiable and thus more sensitive to epigenetic factors than the sympathetic branch of the ANS, which may be linked to foundational survival circuits and less malleable. The flexibility of this “olfaction-autonomic state” circuit was also influenced by sex hormonal status (gender and menstrual stage matter).
In line with this latter finding, the second study by Carnevali et al. highlights the importance of considering biological sex in the analysis and interpretation of HRV data in rats and in other mammals including humans. Moreover, because of the importance of the body size on cardiac chronotropy, this study shows a contrast between the neurometric HRV and the allometric heart rate.
The third study by Williamson et al., advocates for noninvasive VNS to counteract the epigenetics of brain aging without causing side effects in this vulnerable population. The main putative mechanisms involved are reviewed (notably neurotransmitter and functional connectivity changes besides control of inflammation) as well as vagus nerve changes with age, in order to delay the onset of neurodegenerative diseases, thanks to optimized noninvasive VNS protocols in addition to existing behavioral interventions.
The final paper by Konakoglu et al. focuses on the bidirectional effect of auricular vagus nerve stimulation, challenging future VNS clinical trials to assess efficiency at both peripheral and central levels. Moreover, the critical Research Topic of the targeting of the proper ear to stimulate (right or left) is assessed in this study, knowing that noninvasive VNS has been currently administered in a unilateral-left fashion (Badran et al., 2019). Interestingly, Konakoglu et al. findings do not support this left-only convention, as another recent paper (Peng et al., 2023), both suggesting that the choice of the ear should depend mainly on the localization of the targeted lesions (either brain or body lesions) to treat.
Conclusion
Epigenetics provides a revolutionary perspective on the dynamic nature of gene expression and a potential for recovery. The four articles support vagus nerve as a pivotal epigenetic transducer, sensitive to several modifications of the environment of the host (like odors and the localization of the stimulation on the body) or of the host itself (age and hormonal status), impacting both central (EEG modification) and peripheral nervous system (wrist extension muscles modification), thus confirming its bidirectional role (bottom-up and top-down). But above all, they enlighten the roadmap for future VNS clinical trials, by emphasizing the key role of sex and age Research Topic of the host, as well as the choice of the nature of stimulation applied to the vagus nerve and proper ear targeting, opening new avenues for personalized medicine.
Moreover, unraveling the role of VNS on genetic expression is likely to allow valuable insights into optimizing the complex interplay between nature and nurture, challenging the notion of predetermined destiny thanks to noninvasive preventive therapeutic interventions. Last but not least, the knowledge gained may also ensure a more equitable access to healthcare, considering the vast potential of portals to stimulate vagal function, including an olfactive neuromodulation in case of headache, for instance. Thus, as suggested by the polyvagal Theory, vagus-nerve-mediated drive of homeostasis will ultimately support mammalian sociality with all it biobehavioral benefits (Porges, 2021; Porges, 2023).
Statements
Author contributions
CMR: Conceptualization, Writing–original draft, review and editing. AN: review and editing. EM: Supervision, review and editing. SP: Supervision, review and editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbdolmalekyH. M.MartinM.ZhouJ.-R.ThiagalingamS. (2023). Epigenetic alterations of brain non-neuronal cells in major mental diseases. Genes14, 896. 10.3390/genes14040896
2
BadranB. W.YuA. B.AdairD.MappinG.DeVriesW. H.JenkinsD. D.et al (2019). Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): technique, targeting, and considerations. JoVE2019, 58984. 10.3791/58984
3
BersonA.NativioR.BergerS. L.BoniniN. M. (2018). Epigenetic regulation in neurodegenerative diseases. Trends Neurosci.41, 587–598. 10.1016/j.tins.2018.05.005
4
BinnieA.TsangJ. L. Y.HuP.CarrasqueiroG.Castelo-BrancoP.Dos SantosC. C. (2020). Epigenetics of sepsis. Epigenetics Sepsis48, 745–756. 10.1097/CCM.0000000000004247
5
ChenH.FengZ.MinL.DengW.TanM.HongJ.et al (2022). Vagus nerve stimulation reduces neuroinflammation through microglia polarization regulation to improve functional recovery after spinal cord injury. Front. Neurosci.16, 813472. 10.3389/fnins.2022.813472
6
EspositoG.AzhariA.BorelliJ. L. (2018). Gene × environment interaction in developmental disorders: where do we stand and what’s next?Front. Psychol.9, 2036. 10.3389/fpsyg.2018.02036
7
FüllingC.DinanT. G.CryanJ. F. (2019). Gut microbe to brain signaling: what happens in vagus. Neuron101, 998–1002. 10.1016/j.neuron.2019.02.008
8
GidronY.DeschepperR.De CouckM.ThayerJ.VelkeniersB. (2018). The vagus nerve can predict and possibly modulate non-communicable chronic diseases: introducing a neuroimmunological paradigm to public health. JCM7, 371. 10.3390/jcm7100371
9
GilK.BugajskiA.KurnikM.ThorP. (2013). Electrical chronic vagus nerve stimulation activates the hypothalamic-pituitary-adrenal axis in rats fed high-fat diet. Neuro Endocrinol. Lett.34, 314–321.
10
HamiltonP. J.NestlerE. J. (2019). Epigenetics and addiction. Curr. Opin. Neurobiol.59, 128–136. 10.1016/j.conb.2019.05.005
11
HilzM. J. (2022). Transcutaneous vagus nerve stimulation - a brief introduction and overview. Aut. Neurosci.243, 103038. 10.1016/j.autneu.2022.103038
12
JeffriesM. A. (2020). “The development of epigenetics in the study of disease pathogenesis,” in Epigenetics in allergy and autoimmunity, advances in experimental medicine and biology. Editors ChangC.LuQ. (Singapore: Springer Singapore), 57–94. 10.1007/978-981-15-3449-2_2
13
KeuteM.GharabaghiA. (2021). Brain plasticity and vagus nerve stimulation. Aut. Neurosci.236, 102876. 10.1016/j.autneu.2021.102876
14
LewisG. F.FurmanS. A.McCoolM. F.PorgesS. W. (2012). Statistical strategies to quantify respiratory sinus arrhythmia: are commonly used metrics equivalent?. Biol. Psychol.89 (2), 349–364.
15
MolM. B. A.StrousM. T. A.Van OschF. H. M.VogelaarF. J.BartenD. G.FarchiM.et al (2021). Heart-rate-variability (HRV), predicts outcomes in COVID-19. PLoS ONE16, e0258841. 10.1371/journal.pone.0258841
16
MorrisonR. A.DanaphongseT. T.PruittD. T.AdcockK. S.MathewJ. K.AbeS. T.et al (2020). A limited range of vagus nerve stimulation intensities produce motor cortex reorganization when delivered during training. Behav. Brain Res.391, 112705. 10.1016/j.bbr.2020.112705
17
PalS.TylerJ. K. (2016). Epigenetics and aging. Sci. Adv.2, e1600584. 10.1126/sciadv.1600584
18
PeeryR. C.PammiM.ClaudE.ShenL. (2021). Epigenome – a mediator for host-microbiome crosstalk. Seminars Perinatology45, 151455. 10.1016/j.semperi.2021.151455
19
PengX.Baker-VogelB.SarhanM.ShortE. B.ZhuW.LiuH.et al (2023). Left or right ear? A neuroimaging study using combined taVNS/fMRI to understand the interaction between ear stimulation target and lesion location in chronic stroke. Brain Stimul.16, 1144–1153. 10.1016/j.brs.2023.07.050
20
PérezR. F.TejedorJ. R.FernándezA. F.FragaM. F. (2022). Aging and cancer epigenetics: where do the paths fork?Aging Cell21, e13709. 10.1111/acel.13709
21
PorgesS. W.BazhenovaO. V.BalE.CarlsonN.SorokinY.HeilmanK. J.et al (2014). Reducing auditory hypersensitivities in autistic spectrum disorder: preliminary findings evaluating the listening project protocol. Front. Pediatr.2, 80. 10.3389/fped.2014.00080
22
PorgesS. W. (2021). Polyvagal theory: a biobehavioral journey to sociality. Compr. Psychoneuroendocrinology7, 100069. 10.1016/j.cpnec.2021.100069
23
PorgesS. W. (2023). The vagal paradox: a polyvagal solution. Compr. Psychoneuroendocrinology16, 100200. 10.1016/j.cpnec.2023.100200
24
RajabaleeN.KozlowskaK.LeeS. Y.SavageB.HawkesC.SicilianoD.et al (2022). Neuromodulation using computer-altered music to treat a ten-year-old child unresponsive to standard interventions for functional neurological disorder. Harv Rev. Psychiatry30, 303–316. 10.1097/HRP.0000000000000341
25
SunL.ZhangH.GaoP. (2022). Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell13, 877–919. 10.1007/s13238-021-00846-7
26
SuraceA. E. A.HedrichC. M. (2019). The role of epigenetics in autoimmune/inflammatory disease. Front. Immunol.10, 1525. 10.3389/fimmu.2019.01525
27
WuX.LiW.ZhengY. (2020). Recent progress on relevant microRNAs in autism spectrum disorders. IJMS21, 5904. 10.3390/ijms21165904
28
ZhangL.LiuY.LuY.WangG. (2022). Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases. Biochem. Pharmacol.206, 115295. 10.1016/j.bcp.2022.115295
Summary
Keywords
noninvasive vagus nerve stimulation, prevention, epigenetics, heart rate variability, personalised medicine
Citation
Rangon CM, Niezgoda A, Moyse E and Porges SW (2023) Editorial: Vagus nerve-mediated drive in supporting homeostasis: optimizing global health through monitoring and stimulating vagal function. Front. Physiol. 14:1279258. doi: 10.3389/fphys.2023.1279258
Received
17 August 2023
Accepted
23 August 2023
Published
06 September 2023
Volume
14 - 2023
Edited and reviewed by
Geoffrey A. Head, Baker Heart and Diabetes Institute, Australia
Updates
Copyright
© 2023 Rangon, Niezgoda, Moyse and Porges.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Claire Marie Rangon, cmrangon@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.